Author:
Geddes John R.,Calabrese Joseph R.,Goodwin Guy M.
Abstract
BackgroundThere is uncertainty about the efficacy of lamotrigine in bipolar depressive episodes.AimsTo synthesise the evidence for the efficacy of lamotrigine in bipolar depressive episodes.MethodSystematic review and meta-analysis of individual patient data from randomised controlled trials comparing lamotrigine with placebo.ResultsIndividual data from 1072 participants from five randomised controlled trials were obtained. More individuals treated with lamotrigine than placebo responded to treatment on both the Hamilton Rating Scale for Depression (HRSD) (relative risk (RR)=1.27, 95% CI 1.09–1.47, P=0.002) and Montgomery– åsberg Depression Rating Scale (MADRS) (RR=1.22, 95% CI 1.06–1.41, P=0.005). There was an interaction (P=0.04) by baseline severity of depression: lamotrigine was superior to placebo in people with HRSD score >24 (RR=1.47, 95% CI 1.16–1.87, P=0.001) but not in people with HRSD score 24 (RR=1.07, 95% CI 0.90–1.27, P=0.445).ConclusionsThere is consistent evidence that lamotrigine has a beneficial effect on depressive symptoms in the depressed phase of bipolar disorder. The overall pool effect was modest, although the advantage over placebo was larger in more severely depressed participants.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Cited by
329 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献